000 01457 a2200385 4500
005 20250518040144.0
264 0 _c20190925
008 201909s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-19-1065
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTao, Jessica J
245 0 0 _aFirst-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cSep 2019
300 _a5458-5465 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aActivins
650 0 4 _aAntineoplastic Agents
650 0 4 _aGranulosa Cells
650 0 4 _aHumans
650 0 4 _aMaximum Tolerated Dose
650 0 4 _aNeoplasms
650 0 4 _aOvarian Neoplasms
650 0 4 _aTreatment Outcome
700 1 _aCangemi, Nicholas A
700 1 _aMakker, Vicky
700 1 _aCadoo, Karen A
700 1 _aLiu, Joyce F
700 1 _aRasco, Drew W
700 1 _aNavarro, Willis H
700 1 _aHaqq, Christopher M
700 1 _aHyman, David M
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 25
_gno. 18
_gp. 5458-5465
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-19-1065
_zAvailable from publisher's website
999 _c29670406
_d29670406